I am currently the Associate Dean (Learning Enhancement) for the Science Faculty at the University of Strathclyde. I am also a Reader in Pharmacology and the Director of Biomolecular Science (BMS) Programmes in the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). I lead the design and development of Strathclyde’s BMS curriculum and successfully led the re-accreditations for the BMS programmes with the Institute of Biomedical Science (IBMS) in 2023 and the Royal Society of Biology (RSB) in 2024.

I am working on establishing alternative models for teaching practical pharmacology, collaborating with UK-based pharmacology educators to move away from the use of rodent models. One of my key interests is promoting inclusive education in STEM to make pharmacology accessible to diverse learners.

I was elected as a Fellow of the British Pharmacological Society (BPS) in 2021 and as an Honorary BPS Fellow in 2023. In the same year, I was honored to receive the British Pharmacological Society Rang Prize for Outstanding Achievement in Teaching. I serve as a Reviewing Editor for the BPS Journal, Pharmacological Research & Perspectives (PR&P) and I am a member of the BPS engagement and Awards Committees (since 2020). 

Since 2021, I have been part of the Core Concepts of Pharmacology research team, and I currently serve as the Secretary of the IUPHAR-Education Section.

I have led on the Career Progression Working Group on the SIPBS Athena SWAN Self-Assessment Team (SIPBS-WIDE) since 2015. I was part of the SAT team leading the Athena SWAN Bronze (in 2017) and Silver (in 2021) awards. 

Previous leadership roles Include:

• Editor-in-Chief of the BPS Pharmacology Matters magazine (2017-2022)
• Elected member and co-Chair of the RSE Young Academy of Scotland (RSE-YAS, 2018 cohort)
• RSE-YAS Theme Lead for Health (2019-2021).
• SIPBS Public Engagement and Outreach Coordinator (BMS) with Dr Zahra Rattray (Pharmacy) from 2017-2023. 
• Winston Churchill Memorial Trust Fellow (2017)  

My field of expertise is G protein-coupled receptor (GPCR)-dependent regulation of cardiovascular function, with a particular focus on the proteinase-activated receptors (PARs) and purinergic P2Y receptor families. My research investigates the molecular mechanisms of GPCR, gap junction, and damage-associated molecular pattern (DAMP) signaling in processes that underpin platelet function, cardiovascular inflammation, anti-cancer therapy-induced cardiotoxicity, and skeletal muscle function in ageing, particularly its impact on cardiovascular health. I am especially interested in the interplay between muscle and cardiovascular systems in the context of inflammation and vascular dysfunction. I co-led the Cardiovascular and Metabolic Diseases (CMVD) research group with Dr Susan Currie from 2017 to 2023.

I have a strong interest in research-led teaching, particularly in developing alternative models that align with the principles of the 3Rs (Replacement, Reduction, and Refinement), which can be applied across both research and teaching settings. My work includes exploring the use of 3D printing technology to develop human-body-on-a-chip systems and advancing more sustainable models as alternatives to rodent models in research. These efforts aim to provide innovative, ethical, and environmentally friendly approaches to pharmacological and biomedical science research and education.

I am the Biomolecular Sciences (BMS) Programme Director (2023–2027) and a Senior Fellow of the Higher Education Academy (SFHEA), with a Postgraduate Diploma in Academic Practice. In this role, I lead the strategic development and delivery of the BMS programmes, ensuring they remain innovative, inclusive, and aligned with current scientific and educational advancements.

I am an active member of the International Union of Basic & Clinical Pharmacology (IUPHAR) Core Concepts in Pharmacology Research Team, where I contribute to global efforts to enhance pharmacology education and promote best practices in teaching and research. I currently serve as the external examiner for the Applied Medical Sciences (AMS) degree programme at Swansea University and for the BSc Chemistry of Pharmaceutical Compounds programme (Bioscience areas) at University College Cork, ensuring the maintenance of high academic standards across these programmes.

In my teaching, I coordinate BM434 and BM941 Clinical Pharmacology and lead the design of the BM214 and BM327 Pharmacology laboratories, where I integrate my research interests in alternative models that align with the 3Rs (Replacement, Reduction, and Refinement). This includes incorporating innovative approaches, such as the use of 3D printing technology to develop human-body-on-a-chip systems and advancing sustainable alternatives to traditional rodent models. I also deliver teaching across a wide range of undergraduate and postgraduate courses, emphasising inclusive and research-led approaches to support diverse learners in pharmacology.